<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g124" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-123.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-47.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-87.html" >Diseases Characterized by Genital, Anal, or Perianal Ulcers</a><span class="carrot"> > </span>
                    <a href="lv-87.html" >Syphilis</a><span class="carrot"> > </span>
                    <a href="lv-118.html" >Neurosyphilis</a><span class="carrot"> > </span>
                    <a href="lv-123.html" >Special Considerations</a><span class="carrot"> > </span>Penicillin Allergy
            </div>
            </br><h5 class="sgc-1 sgc-1" id="sigil_toc_id_124">
 Penicillin Allergy
</h5>
<p>
 Limited data suggest that ceftriaxone 2 g daily either IM or IV for 10&ndash;14 days can be used as an alternative treatment for patients with neurosyphilis (221,222). However, the possibility of cross-reactivity between ceftriaxone and penicillin exists. Other regimens have not been adequately evaluated for treatment of neurosyphilis. Therefore, if concern exists regarding the safety of ceftriaxone for a patient with neurosyphilis, skin testing should be performed (if available) to confirm penicillin allergy and, if necessary, desensitization in consultation with a specialist.
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

